GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.25
Bid: 15.00
Ask: 15.50
Change: -0.50 (-3.23%)
Spread: 0.50 (3.333%)
Open: 15.00
High: 15.50
Low: 14.65
Prev. Close: 15.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS AND LOSERS SUMMARY: Unilever, Kingfisher Up As Aberdeen, SSE Drop

Thu, 23rd Jul 2015 09:29

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
----------
FTSE 100 - WINNERS
----------
Unilever, up 2.3%. The maker of consumer products reported a drop in profit in the first half of 2015, although revenue grew in each of its Personal Care, Foods, Refreshment and Home Care divisions. It reported a 14% drop in pretax profit to EUR3.6 billion from EUR4.2 billion in the first half, although revenue grew 12% to EUR27 billion from EUR24.1 billion. Both are at reported currencies. At constant currencies, revenue grew 1.8% and pretax profit fell 21%. On an underlying basis, which strips out the impact of currency movements and any acquisitions or disposals, sales grew 2.9% which according to Shore Capital was slightly ahead of the 2.7% consensus, while second quarter underlying sales growth, also of 2.9%, beat consensus of 2.6% growth.

Fresnillo, up 0.8%, and Randgold Resources, up 1.5%. Gold miners are benefiting from the rise in the gold price, which is at USD1,104.63 Thursday morning. After a huge sell-off earlier this week, the yellow metal touched a low of USD1,073.40 but has slightly recovered since.

Kingfisher, up 1.6%. The DIY retailer reported a rise in sales on a constant currency basis in the second quarter of its financial year, as it demonstrated growth in each of the regions in which it operates and as it continues with its strategy to create a unified 'ONE' Kingfisher. It said that total sales in the 10 weeks to July 11 grew 4.8% on a constant currency basis, while like-for-like revenue rose 3.5%.

RELX Group, up 0.7%. The business information provider, also formerly known as Reed Elsevier, reiterated its outlook for 2015 as it posted a flat pretax profit for its first half, in its first results as a consolidated group. The company recently transferred the assets of its UK and Dutch parent companies into a new single group entity called RELX Group.
----------
FTSE 100 - LOSERS
----------
Aberdeen Asset Management, down 6.2%. The company said its assets under management dropped in the third quarter of its financial years amid outflows related to volatility in Asian and emerging markets. The asset manager said its assets under management fell to GBP307.3 billion at the end of June, down from GBP330.6 billion at the end of March. Aberdeen attributed the fall to market conditions and foreign exchange movements.

SSE, down 4.4%. The energy provider said production across most all of its divisions, except coal, rose in the first quarter of the financial year, but it reported a fall in customer accounts and average customer consumption. It said the number of retail electricity and gas customers at the end of March had fallen to 8.49 million from 8.58 million at the end of March 2014. Average customer consumption of electricity in the first quarter fell to 822,000 kilowatt hours from 853,000 kilowatt hours a year earlier. However, average gas consumption experienced a small lift to 75 therms per customer from 68 therms.

Ashtead Group, down 3.7%. Shares in the industrial equipment rental company are taking a hit after US peer United Rentals reported weak number in its last update. United Rentals reported second-quarter net income of USD86 million, down from USD94 million from last year.

SABMiller, down 0.6%. The brewer said its reported net producer revenue dropped in the first quarter of its financial year, but said it grew on a constant currency basis, as volume growth was mixed in different geographic regions. The maker of Grolsch, Peroni and Coors beers said that reported net producer revenue in the quarter to June 30 declined 10% due to the depreciation of some currencies against the US dollar, but grew 3% on a constant currency basis.
----------
FTSE 250 - WINNERS
----------
Acacia Mining, up 2.3%, Lonmin, up 1.3%. The miners are benefiting from the rise in gold prices.

Halma, up 0.5%. The safety, heath and environmental technology group said it has seen constant currency revenue growth in all of its divisions in the first quarter. Halma said its order intake has been ahead of revenue in the quarter to July 4 and said it looks well positioned to meet its expectations for the second half of the year.
----------
FTSE 250 - LOSERS
----------
Howden Joinery Group, down 3.6%. The kitchens and joinery products manufacturer hiked its interim dividend on the back of a rise in pretax profit and revenue in the first half of 2015. It said its pretax profit in the half to the end of June was up to GBP59.2 million from GBP57.2 million, with growth held back somewhat by higher selling and distribution costs and administrative expenses, as the group continues to invest to expand its operations. However, N+1 Singer analyst Matthew McEachran says that, "with significant cost increases, partly from volume and partly investment in capability/capacity, the first half results were slightly behind [N+1 Singer's expectations] and upgrades of any significance look unlikely."

Britvic, down 2.0% to 720.50 pence. The company said it has bought Brazilian soft drinks company Empresa Brasileira de Bebidas e Alimentos for GBP113.6 million, partly financed by a share issue. Britvic said it will place up to 12.4 million shares, 4.97% of its current total, through an accelerated bookbuild process in order to raise GBP90 million to fund its acquisition of ebba, which would equate to 725.81p per share. Britvic also reported that revenue grew 1% in the third quarter of its financial year to GBP322.3 million.
----------
AIM ALL-SHARE - WINNERS
----------
Atlantic Coal, up 10%. The company reported a large rise in sales in the second quarter after it began selling run of mine anthracite coal at the start of 2015, and the company said it has beefed up its stockpiles in preparation for the winter. The US-based coal miner reported a 12% rise in run of mine anthracite production in the second quarter of 160,583 tonnes from the 136,981 tonnes produced in the first quarter.

Victoria Oil & Gas, up 7%. The gas utility company said both gas production and sales more than doubled in the second quarter of 2015. Average gas production in the second quarter was 12.6 million standard cubic feet per day. That is more than double the 4.5 million cubic feet produced in the first quarter of 2015 and the 2.6 million produced a year earlier. Gas sales also leapt to 1.12 billion standard cubic feet from only 404.5 million cubic feet in the previous quarter and from 281.1 million cubic feet a year earlier.

Abcam, up 5.1%. The life science research tools supplier said it expects to post revenue growth of over 12% for its recently ended financial year to end-June. Abcam said its gross margins for the year are likely to be in line with those it saw in its first half, and slightly increased from its previously financial year.
----------
AIM ALL-SHARE - LOSERS
----------
Angle, off 5.7%. The company posted a widened pretax loss for its recently ended financial year, as it continued to progress its Parsortix cell separation system towards commercialisation. For the year to end-April the company posted a pretax loss of GBP3.9 million, widened from a pretax loss GBP2.2 million a year before, due to an increase in operating costs, as it increased investment in developing its key product Parsortix.

Elektron Technology, down 5.5%. The company said that revenue in its first half is expected to be marginally lower than in the previous year, as it continues to see declines in markets for some of its legacy products. However, for the half year to end-July trading for the company's established business is expected to show a "significant improvement" over the previous year.
----------
By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2022 10:27

Angle wins additional contract with large-scale pharma company

(Sharecast News) - Liquid biopsy company Angle has secured an additional contract with its first large-scale pharmaceutical services customer.

Read more
22 Jun 2022 10:01

Angle wins cancer monitoring contract for Parasortix system

(Alliance News) - Angle PLC on Wednesday said it has secured further business with its "first large scale pharma services" customer.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
14 Jun 2022 20:13

IN BRIEF: Angle's Parsortix performs well on prostate cancer patients

Angle PLC - Surrey, England-based medical diagnostics company - Notes researchers at King's College London published data investigating the role of invasive cellular protrusion, known as invadopodia, activity in prostate cancer, and a potential role in the formation of circulating tumour cells. Researchers used Angle's Parsortix system's ability to isolate CTCs from the blood of prostate cancer patients. Parsortix system isolates CTCs in 94% of prostate cancer patients, showing some association with matrix degradation and invasive cellular protrusion formation. This may allow novel therapeutic development targeting the mechanisms of invadopodia and reducing metastatic spread of the cancer, it says.

Read more
30 May 2022 15:21

IN BRIEF: Angle partners with US urology group for Parasortix study

Angle PLC - Surrey, England-based medical diagnostics company - Establishes partnership with MidLantic Urology to evaluate the use of its Parasortix system in prostate cancer clinical studies. MidLantic is as an affiliate of special urology services provider Solaris, which has over 500 clinical urology providers across 179 locations in the US, with over 729,000 annual patients. Angle hopes the collaboration will "enable potential sales" to Solaris' patient base. The first study is expected to start in the third quarter of 2022, with results to be available in 2023.

Read more
27 May 2022 21:25

TRADING UPDATES: Savannah Energy to develop new projects in Chad

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 May 2022 21:19

IN BRIEF: Angle shares rocket as Parasortix receives US FDA approval

Angle PLC - Surrey, England-based medical diagnostics company - Receives approval from the US Food & Drug Administration for the use of its Parasortix system for use in metastatic breast cancer patients. Parasortix isolates circulating tumour cells from the blood which can aid in the diagnosis, characterisation and monitoring of cancer, and do so in a much less invasive fashion than traditional tissue biospy.

Read more
25 May 2022 17:06

LONDON MARKET CLOSE: Stocks rise ahead of US Fed meeting minutes

(Alliance News) - Stocks in London ended mostly higher on Wednesday as market participants look ahead to the latest minutes from the US Federal Reserve at 1900 BST.

Read more
20 May 2022 13:07

Angle's Parsortix to be used in 'significant' prostate cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that Prostate Cancer UK has approved funding for a "significant" clinical study at the Barts Cancer Institute of the Queen Mary University of London.

Read more
20 May 2022 09:48

IN BRIEF: Cancer study using Angle's Parasortix secures funding

Angle PLC - Surrey, England-based medical diagnostics company - Says Prostate Cancer UK has given a GBP750,000 grant for a clinical study at Barts Cancer Institute, Queen Mary University of London. The trial will follow 200 men with localised prostate cancer over five years, assessed using Angle's Parsortix system, in bid to see whether the cancer will eventually spread.

Read more
28 Apr 2022 16:10

EARNINGS UPDATES: Brave Bison notes first profit; Angle widens loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Apr 2022 16:10

UK earnings, trading statements calendar - next 7 days

Friday 22 April 
Alphawave IP Group PLCFull Year Results
Petropavlovsk PLCTrading Statement
Record PLCTrading Statement
Serabi Gold PLCFull Year Results
Zinc Media Group PLCFull Year Results
Monday 25 April 
Access Intelligence PLCFull Year Results
Arecor Therapeutics PLCFull Year Results
Audioboom Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Chapel Down Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Vector Capital PLCFull Year Results
Tuesday 26 April 
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Billington Holdings PLCFull Year Results
Corero Network Security PLCFull Year Results
Focusrite PLCHalf Year Results
Futura Medical PLCFull Year Results
Gaming Realms PLCFull Year Results
Hochschild Mining PLCTrading Statement
HSBC Holdings PLCQ1 Results (at 0500 BST)
Immotion Group PLCFull Year Results
IWG PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Learning Technologies Group PLCFull Year Results
Loungers PLCTrading Statement
National Express Group PLCTrading Statement
Northcoders Group PLCFull Year Results
Nostrum Oil & Gas PLCFull Year Results
PureTech Health PLCFull Year Results
RWS Holdings PLCHalf Year Results
Taylor Wimpey PLCFull Year Results
Wednesday 27 April 
1Spatial PLCFull Year Results
AB Dynamics PLCHalf Year Results
Anglo Pacific Group PLCQ1 Results
Aveva Group PLCTrading Statement
City Pub Group PLCFull Year Results
Drax Group PLCTrading Statement
Fresnillo PLCQ1 Production Results
GlaxoSmithKline PLCQ1 Results
Go-Ahead Group PLCHalf Year Results
Lloyds Banking Group PLCQ1 Results
London Stock Exchange Group PLCTrading Statement
Network International Holdings PLCTrading Statement
Nichols PLCFull Year Results
Persimmon PLCTrading Statement
Primary Health Properties PLCTrading Statement
RPS Group PLCQ1 Results
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Yamana Gold IncTrading Statement
Thursday 28 April 
Angle PLCFull Year Results
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
C4X Discovery Holdings PLCHalf Year Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCTrading Statement
Howden Joinery Group PLCTrading Statement
HSS Hire Group PLCFull Year Results
Hurricane Energy PLCFull Year Results
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
International Personal Finance PLCTrading Statement
J Sainsbury PLCFull Year Results
Keystone Law Group PLCFull Year Results
Lancashire Holdings LtdQ1 Trading Statement
Novacyt SAFull Year Results
PPHE Hotel Group LtdTrading Statement
Sanderson Design Group PLCFull Year Results
Schroders PLCTrading Statement
Smith & Nephew PLCQ1 Results
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Standard Chartered PLCQ1 Results
Unilever PLCQ1 Results
Whitbread PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Apr 2022 12:25

TRADING UPDATES: Yooma, Love Hemp in UK boost; Peel Hunt tops forecast

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
29 Mar 2022 19:29

IN BRIEF: Angle's Parsortix can help with cancer treatment options

Angle PLC - Surrey, England-based medical diagnostics company - Notes University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Institute has published results of work undertaken in preclinical models of triple-negative breast cancer. Findings show isolation of live circulating tumour cells from a simple blood draw, using Angle's Parsortix system, can provide rapid information on patient response to existing chemotherapy treatments that can target metastasis more effectively than tumour growth.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.